Condition: Acute Coronary Syndrome · Sponsor: Sohag University
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
This description comes directly from the study's public registry record.
Amira Elbasuony, resident · 01113695925 · amiraelbadawy518@gmail.com
Always discuss trial participation with your own doctor first.
| Sohag faculty of medicine | Sohag, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06673381